LeMaitre Vascular (NASDAQ:LMAT) Stock Price Expected to Rise, Lake Street Capital Analyst Says

LeMaitre Vascular (NASDAQ:LMAT) had its price target hoisted by research analysts at Lake Street Capital from $105.00 to $110.00 in a note issued to investors on Friday,Benzinga reports. The brokerage presently has a “buy” rating on the medical instruments supplier’s stock. Lake Street Capital’s price objective would indicate a potential upside of 19.76% from the company’s previous close.

LMAT has been the subject of a number of other reports. Barrington Research lowered shares of LeMaitre Vascular from an “outperform” rating to a “market perform” rating in a research report on Friday. StockNews.com downgraded shares of LeMaitre Vascular from a “buy” rating to a “hold” rating in a research note on Friday, December 13th. Oppenheimer downgraded shares of LeMaitre Vascular from an “outperform” rating to a “market perform” rating in a research note on Friday. Finally, Wells Fargo & Company started coverage on shares of LeMaitre Vascular in a research note on Thursday, February 13th. They issued an “equal weight” rating and a $95.00 target price on the stock. Five research analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $95.25.

LeMaitre Vascular Trading Down 8.1 %

Shares of LMAT stock opened at $91.85 on Friday. LeMaitre Vascular has a 12 month low of $62.39 and a 12 month high of $109.58. The stock has a market cap of $2.07 billion, a PE ratio of 50.19, a price-to-earnings-growth ratio of 2.22 and a beta of 0.96. The company’s fifty day moving average price is $96.89 and its 200-day moving average price is $94.73.

LeMaitre Vascular (NASDAQ:LMAT) last issued its earnings results on Thursday, February 27th. The medical instruments supplier reported $0.49 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.49. LeMaitre Vascular had a net margin of 19.40% and a return on equity of 13.15%. The business had revenue of $55.81 million during the quarter, compared to analysts’ expectations of $55.99 million. On average, sell-side analysts forecast that LeMaitre Vascular will post 1.94 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the stock. Creative Planning grew its stake in LeMaitre Vascular by 20.7% during the 3rd quarter. Creative Planning now owns 3,594 shares of the medical instruments supplier’s stock worth $334,000 after purchasing an additional 617 shares in the last quarter. Raymond James & Associates increased its holdings in shares of LeMaitre Vascular by 2.6% in the 3rd quarter. Raymond James & Associates now owns 29,592 shares of the medical instruments supplier’s stock valued at $2,749,000 after acquiring an additional 748 shares during the period. Rice Hall James & Associates LLC increased its holdings in shares of LeMaitre Vascular by 15.7% in the 3rd quarter. Rice Hall James & Associates LLC now owns 261,306 shares of the medical instruments supplier’s stock valued at $24,273,000 after acquiring an additional 35,383 shares during the period. Oak Ridge Investments LLC acquired a new position in shares of LeMaitre Vascular in the 3rd quarter valued at $2,020,000. Finally, Conestoga Capital Advisors LLC increased its holdings in shares of LeMaitre Vascular by 1.9% in the 3rd quarter. Conestoga Capital Advisors LLC now owns 1,978,351 shares of the medical instruments supplier’s stock valued at $183,769,000 after acquiring an additional 36,850 shares during the period. Hedge funds and other institutional investors own 84.64% of the company’s stock.

LeMaitre Vascular Company Profile

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.